Table 4 Causes of Death of Participants with Prior Heart Failure Hospitalization
Chlorthalidone Treatment Group | Doxazosin Treatment Group | |
|---|---|---|
No. of participants with hospitalization for heart failure prior to death* | 280 | 317 |
No. of deaths (%) | 52 (18.6) | 70 (22.1) |
Cause of death (%) | ||
Myocardial infarction | 7 (13.5) | 5 (7.1) |
Definite CHD | 5 (9.6) | 9 (12.9) |
Possible CHD | 1 (1.9) | 7 (10.0) |
Stroke | 1 (1.9) | 3 (4.3) |
Heart failure | 11 (21.2) | 12 (17.1) |
Other CVD | 4 (7.7) | 7 (10.0) |
Total cardiovascular deaths (%) | 29 (55.8) | 43 (61.4) |
Cancer | 8 (15.4) | 6 (8.6) |
Kidney disease | 1 (1.9) | 1 (1.4) |
Accident/suicide/homicide | 0 (0) | 1 (1.4) |
Other non-CVD | 8 (15.4) | 11 (15.7) |
Unknown | 6 (11.5) | 8 (11.4) |